TY - JOUR AU - Jenkins C. AU - Chapman K. AU - Donohue J. AU - Roche N. AU - Tsiligianni I. AU - Han M. AB -

Chronic obstructive pulmonary disease (COPD) is a highly debilitating disease that represents a substantial and growing health burden in women. There is increasing evidence for gender-related differences in COPD risk, progression and outcomes. However, the disease receives scant attention as a women's health issue. Thus, a multifaceted approach is required to address COPD in women, including greater awareness, minimisation of risk and further elucidation of the gender-specific factors (biological and cultural) that affect risk, disease progression and treatment success. Here we review current literature on the topic and provide suggestions for achieving better outcomes for the millions of women with COPD worldwide.

AD - The George Institute for Global Health, Sydney, Australia. Electronic address: christine.jenkins@sydney.edu.au.
Asthma and Airway Centre, University Health Network, Toronto Western Hospital, Rm 7-451 East Wing, 399 Bathurst Street, Toronto, ON, Canada.
Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Respiratory and Intensive Care Medicine, Cochin Hospital Group, AP-HP, EA2511 University Paris Descartes, Paris, France.
University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, P.O 9700 AD, Groningen, The Netherlands.
Division of Pulmonary and Critical Care, University of Michigan, Ann Arbor, MI, USA. AN - 27816445 BT - Chest CN - [IF]: 7.132 DP - NLM ET - 2016/11/07 J2 - Chest LA - Eng LB - AUS
RSP
FY17 N1 - Jenkins, Christine R
Chapman, Kenneth R
Donohue, James F
Roche, Nicolas
Tsiligianni, Ioanna
Han, MeiLan K
Review
United States
Chest. 2016 Nov 2. pii: S0012-3692(16)62316-4. doi: 10.1016/j.chest.2016.10.031. N2 -

Chronic obstructive pulmonary disease (COPD) is a highly debilitating disease that represents a substantial and growing health burden in women. There is increasing evidence for gender-related differences in COPD risk, progression and outcomes. However, the disease receives scant attention as a women's health issue. Thus, a multifaceted approach is required to address COPD in women, including greater awareness, minimisation of risk and further elucidation of the gender-specific factors (biological and cultural) that affect risk, disease progression and treatment success. Here we review current literature on the topic and provide suggestions for achieving better outcomes for the millions of women with COPD worldwide.

PY - 2016 SN - 1931-3543 (Electronic)
0012-3692 (Linking) ST - ChestChest T2 - Chest TI - Improving the Management of COPD in Women Y2 - FY17 ER -